Literature DB >> 21227475

Phenotypes and functions of persistent Sendai virus-induced antibody forming cells and CD8+ T cells in diffuse nasal-associated lymphoid tissue typify lymphocyte responses of the gut.

Rajeev Rudraraju1, Sherri Surman1, Bart Jones1, Robert Sealy1, David L Woodland2, Julia L Hurwitz1,3.   

Abstract

Lymphocytes of the diffuse nasal-associated lymphoid tissue (d-NALT) are uniquely positioned to tackle respiratory pathogens at their point-of-entry, yet are rarely examined after intranasal (i.n.) vaccinations or infections. Here we evaluate an i.n. inoculation with Sendai virus (SeV) for elicitation of virus-specific antibody forming cells (AFCs) and CD8(+) T cells in the d-NALT. Virus-specific AFCs and CD8(+) T cells each appeared by day 7 after SeV inoculation and persisted for 8 months, explaining the long-sustained protection against respiratory virus challenge conferred by this vaccine. AFCs produced IgM, IgG1, IgG2a, IgG2b and IgA, while CD8+ T cells were cytolytic and produced low levels of cytokines. Phenotypic analyses of virus-specific T cells revealed striking similarities with pathogen-specific immune responses in the intestine, highlighting some key features of adaptive immunity at a mucosal site.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21227475      PMCID: PMC3941175          DOI: 10.1016/j.virol.2010.12.017

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  60 in total

1.  Induction and visualization of mucosal memory CD8 T cells following systemic virus infection.

Authors:  S K Kim; K S Schluns; L Lefrançois
Journal:  J Immunol       Date:  1999-10-15       Impact factor: 5.422

2.  Analysis of the primary T-cell response to Sendai virus infection in C57BL/6 mice: CD4+ T-cell recognition is directed predominantly to the hemagglutinin-neuraminidase glycoprotein.

Authors:  G A Cole; J M Katz; T L Hogg; K W Ryan; A Portner; D L Woodland
Journal:  J Virol       Date:  1994-11       Impact factor: 5.103

Review 3.  Long-term humoral immunity against viruses: revisiting the issue of plasma cell longevity.

Authors:  M K Slifka; R Ahmed
Journal:  Trends Microbiol       Date:  1996-10       Impact factor: 17.079

4.  Isolation and characterization of mouse nasal-associated lymphoid tissue.

Authors:  H Asanuma; A H Thompson; T Iwasaki; Y Sato; Y Inaba; C Aizawa; T Kurata; S Tamura
Journal:  J Immunol Methods       Date:  1997-03-28       Impact factor: 2.303

5.  Intranasal Sendai virus vaccine protects African green monkeys from infection with human parainfluenza virus-type one.

Authors:  J L Hurwitz; K F Soike; M Y Sangster; A Portner; R E Sealy; D H Dawson; C Coleclough
Journal:  Vaccine       Date:  1997-04       Impact factor: 3.641

6.  Efficient priming of CD8+ memory T cells specific for a subdominant epitope following Sendai virus infection.

Authors:  G A Cole; T L Hogg; M A Coppola; D L Woodland
Journal:  J Immunol       Date:  1997-05-01       Impact factor: 5.422

7.  Age-related development of human memory T-helper and B-cell responses toward parainfluenza virus type-1.

Authors:  F S Smith; A Portner; R J Leggiadro; E V Turner; J L Hurwitz
Journal:  Virology       Date:  1994-12       Impact factor: 3.616

Review 8.  Biology of parainfluenza viruses.

Authors:  R Vainionpää; T Hyypiä
Journal:  Clin Microbiol Rev       Date:  1994-04       Impact factor: 26.132

9.  The MHC class I-restricted T cell response to Sendai virus infection in C57BL/6 mice: a single immunodominant epitope elicits an extremely diverse repertoire of T cells.

Authors:  G A Cole; T L Hogg; D L Woodland
Journal:  Int Immunol       Date:  1994-11       Impact factor: 4.823

10.  The role of beta7 integrins in CD8 T cell trafficking during an antiviral immune response.

Authors:  L Lefrançois; C M Parker; S Olson; W Muller; N Wagner; M P Schön; L Puddington
Journal:  J Exp Med       Date:  1999-05-17       Impact factor: 14.307

View more
  28 in total

1.  Oral retinyl palmitate or retinoic acid corrects mucosal IgA responses toward an intranasal influenza virus vaccine in vitamin A deficient mice.

Authors:  S L Surman; B G Jones; R E Sealy; R Rudraraju; J L Hurwitz
Journal:  Vaccine       Date:  2014-03-21       Impact factor: 3.641

2.  Vitamin A deficiency disrupts vaccine-induced antibody-forming cells and the balance of IgA/IgG isotypes in the upper and lower respiratory tract.

Authors:  Sherri L Surman; Rajeev Rudraraju; Robert Sealy; Bart Jones; Julia L Hurwitz
Journal:  Viral Immunol       Date:  2012-07-19       Impact factor: 2.257

Review 3.  Respiratory syncytial virus vaccine development.

Authors:  Julia L Hurwitz
Journal:  Expert Rev Vaccines       Date:  2011-10       Impact factor: 5.217

4.  Relationships among dissemination of primary parainfluenza virus infection in the respiratory tract, mucosal and peripheral immune responses, and protection from reinfection: a noninvasive bioluminescence-imaging study.

Authors:  Crystal W Burke; Mei Li; Julia L Hurwitz; Peter Vogel; Charles J Russell
Journal:  J Virol       Date:  2015-01-14       Impact factor: 5.103

5.  Antibody-secreting cells in respiratory tract tissues in the absence of eosinophils as supportive partners.

Authors:  Robert E Sealy; Sherri L Surman; Peter Vogel; Julia L Hurwitz
Journal:  Int Immunol       Date:  2016-07-18       Impact factor: 4.823

6.  Reduced frequencies and heightened CD103 expression among virus-induced CD8(+) T cells in the respiratory tract airways of vitamin A-deficient mice.

Authors:  Rajeev Rudraraju; Sherri L Surman; Bart G Jones; Robert Sealy; David L Woodland; Julia L Hurwitz
Journal:  Clin Vaccine Immunol       Date:  2012-03-07

7.  Sendai virus-based RSV vaccine protects African green monkeys from RSV infection.

Authors:  Bart G Jones; Robert E Sealy; Rajeev Rudraraju; Vicki L Traina-Dorge; Brad Finneyfrock; Anthony Cook; Toru Takimoto; Allen Portner; Julia L Hurwitz
Journal:  Vaccine       Date:  2011-11-23       Impact factor: 3.641

8.  Non-random lymphocyte distribution among virus-infected cells of the respiratory tract.

Authors:  Rajeev Rudraraju; Robert E Sealy; Sherri L Surman; Paul G Thomas; Barry H Dayton; Julia L Hurwitz
Journal:  Viral Immunol       Date:  2013-12       Impact factor: 2.257

9.  Intranasal administration of retinyl palmitate with a respiratory virus vaccine corrects impaired mucosal IgA response in the vitamin A-deficient host.

Authors:  Sherri L Surman; Bart G Jones; Rajeev Rudraraju; Robert E Sealy; Julia L Hurwitz
Journal:  Clin Vaccine Immunol       Date:  2014-02-19

10.  Vitamin Supplementation at the Time of Immunization with a Cold-Adapted Influenza Virus Vaccine Corrects Poor Mucosal Antibody Responses in Mice Deficient for Vitamins A and D.

Authors:  S L Surman; R R Penkert; B G Jones; R E Sealy; J L Hurwitz
Journal:  Clin Vaccine Immunol       Date:  2016-01-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.